About fundamentals and sermonizers. Author's response to the letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?"

@article{FunckBrentano2017AboutFA,
  title={About fundamentals and sermonizers. Author's response to the letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?"},
  author={C. Funck-Brentano and J. M{\'e}nard},
  journal={Presse medicale},
  year={2017},
  volume={46 3},
  pages={
          352-353
        }
}
La Presse Medicale - In Press.Proof corrected by the author Available online since jeudi 23 fevrier 2017 
1 Citations

References

SHOWING 1-10 OF 13 REFERENCES
Protecting research subjects--the crisis at Johns Hopkins.
FAAH inhibitors in the limelight, but regrettably
Open letter on access to the BIA 10-2474 clinical trial data
Researchers question design of fatal French clinical trial
French drug trial protocol fails to answer key questions
  • N. Hawkes
  • Medicine
  • BMJ : British Medical Journal
  • 2016
Implications of the BIA‐102474‐101 study for review of first‐into‐human clinical trials
Duham incidents graves surve réalisation d'un essai cl définitif; 2016
  • http: IMG/pdf/2016-012 definitif_rect_20_05.p
  • 2016
Circulaire n DGS/PP1/ 2016/61 du 1 mars 2016 relative aux déclarations des faits nouveaux et des évènements indésirables graves survenant au cours des essais cliniques; 2016
  • [Last accessed:
  • 2016
...
1
2
...